You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Jardiance

Showing 101 - 118 of 118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • Mobile, Alabama
  • +107 more
Nov 12, 2020

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • Mobile, Alabama
  • +108 more
Nov 12, 2020

Type 2 Diabetes Trial in Seoul (Gemigliptin, Dapagliflozin, Empagliflozin)

Unknown status
  • Type 2 Diabetes Mellitus
  • Seoul, Gangseo-Gu, Korea, Republic of
    LG chem
Jun 11, 2018

Diabetes Type 2 Trial in Erlangen (Empagliflozin, Placebo)

Completed
  • Diabetes Mellitus Type 2
  • Erlangen, Bavaria, Germany
    University of Erlangen-Nuremberg
May 9, 2018

Type 2 Diabetes Trial in Changsha (Empagliflozin Tablets, Empagliflozin Tab 25 MG)

Completed
  • Type 2 Diabetes
  • Empagliflozin Tablets
  • Empagliflozin Tab 25 MG
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Feb 20, 2019

SGLT-2 Inhibitors, Advanced Glycation End Products, Diabetes Trial (empagliflozin, linagliptin)

Withdrawn
  • SGLT-2 Inhibitors
  • +2 more
  • (no location specified)
Feb 13, 2018

Heart Failure, Diabetes, Arrythmia Trial (Empagliflozin at a dose of 10 mg/day)

Unknown status
  • Heart Failure
  • +2 more
  • Empagliflozin at a dose of 10 mg/day
  • (no location specified)
Jan 24, 2018

Type2 Diabetes Trial in Taipei (SGLT2 inhibitor (Empagliflozin 25 MG), DPP4 inhibitor (Linagliptin 5 MG))

Unknown status
  • Type2 Diabetes
  • SGLT2 inhibitor (Empagliflozin 25 MG)
  • DPP4 inhibitor (Linagliptin 5 MG)
  • Taipei, Taiwan
    Division of Endocrinology and Metabolism, Department of Internal
Mar 7, 2018

Nocturnal Hypertension, T2DM (Type 2 Diabetes) Trial in Japan (Empagliflozin, Placebo)

Completed
  • Nocturnal Hypertension
  • T2DM (Type 2 Diabetes Mellitus)
  • Fukuoka, Japan
  • +11 more
Mar 25, 2018

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • Anniston, Alabama
  • +618 more
Jun 3, 2022

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • La Mesa, California
  • +519 more
Apr 26, 2021

SIADH Trial in Basel (Empagliflozin, Placebo)

Completed
  • SIADH
  • Basel, Switzerland
    University Hospital Basel
Jun 12, 2019

Type2 Diabetes, NAFLD Trial in Kuala Lumpur (Empagliflozin)

Unknown status
  • Type2 Diabetes
  • NAFLD
  • Kuala Lumpur, Wilayah Persekutuan, Malaysia
    University of Malaya
May 27, 2017

Diabetes Trial (Empagliflozin 25mg)

Completed
  • Diabetes Mellitus
  • Empagliflozin 25mg
  • (no location specified)
Feb 16, 2017

Type 2 Diabetes Trial in Mainz, Neuss (Linagliptin, Placebo, Empagliflozin)

Completed
  • Type 2 Diabetes Mellitus
  • Mainz, Germany
  • +1 more
Feb 23, 2016

Hypertension, Type II Diabetes Trial in Thessaloniki (empagliflozin, Metformin)

Unknown status
  • Hypertension
  • Type II Diabetes
  • Thessaloniki, Greece
    Hypertension 24h ABPM center Papageorgiou Hospital
Apr 6, 2015

Inappropriate ADH Syndrome Trial in Basel (Induced hypotonic hyponatremia - SIAD model, Empagliflozin 25mg Tbl, Placebo

Completed
  • Inappropriate ADH Syndrome
  • Induced hypotonic hyponatremia - SIAD model
  • +2 more
  • Basel, Switzerland
    Department Endocrinology University Hospital Basel
Aug 9, 2016

Meta-analysis in Post-marketing Surveillances for SGLT2

Unknown status
  • Diabetes Mellitus, Type 2
  • SGLT2 Inhibitors
  • (no location specified)
Mar 31, 2016